Sapino sirop extra
Natural health product licensed in Canada
- Other names
- Sirop d'Antan EXTRA
- Licence holder
- DMG Services Inc
- NPN or DIN-HM
- 80033186
- Status
- Active licence
- Licence date
- 28 June 2012
- Revision date
- 30 May 2023
- Form
- Sirop
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
dl-Menthol, miel, Saveur de menthe poivrée, Acide sorbique, Sorbate de potassium, Glycérine, Extrait de Menthe poivrée, Eau purifiée, Essence d'aiguilles de Sapin Canadien, Feuille d'Eucalyptus globulus
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 2 years ; maximum: 4 years | 1 Cuillère à thé | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Enfants et Adolescents | minimum: 5 years ; maximum: 9 years | 1 Cuillère à thé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adolescentes | minimum: 10 years ; maximum: 14 years | 2 Cuillère à thé | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
| Adultes et adolescents | minimum: 15 years | 2 Cuillère à thé | minimum: 2 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Aide à soulager les symptômes et réduire la durée des infections des voies respiratoires supérieures. Thérapie de soutien pour traiter les infections des voies respiratoires supérieures (e.g. le rhume). Utilisée en phytothérapie pour aider à combattre les infections, particulièrement les infections des voies respiratoires supérieures.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Une hypersensibilité (e.g allergie) peut se manifester. Si tel est le cas cesser l'utilisation.
Source
Official Health Canada record, licence 80033186
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging